IP6K1 has been implicated in human liver disease, as hepatic IP6K1 is upregulated in NASH, alcoholic cirrhosis [21], and hepatocellular carcinoma patients [26]. The gene discussed is IP6K1; the disease is metabolic dysfunction-associated steatohepatitis.